Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Also a nice area for us to make the run from on our next leg up!
Held nicely today above a dime. To those that sold, see you at .50 and beyond. A lot of irons in the fire: uplist to Nasdaq, $50M revenue trajectory or $100M with possible merger, growing 340B business, sustained profitability, and so much more. Know what you own or look back and drone about what if’s in fomo fits.
Considering everything that’s on the horizon, makes no sense to me what’s happening here. Stick to the DD and the facts! The fundamentals speak for themselves here.
Nice consolidation pattern happening here at every new level. Higher highs, higher lows. RXMD is just getting started. Sit back and enjoy the view, folks.
The cat is out of the bag, and there’s no holding RXMD back!
Those shares are going into stronger, more informed hands. Still trying to figure out the calculus behind the decision-making because it doesn’t compute but to each their own.
...or even the brewery! :)
Power hour soon. Let’s close strong!
Good for you but that still doesn’t negate the facts. It’s clear that you want to refill the tank at lower price.
IMO, I don’t think the current rise in price is tied to news of the NETE merger. Under current, known fundamentals alone, this should be between .40 and .50 on current revenue alone. News of the NETE merger and S-1 is what will get this to $1+ in value. Let’s not belittle this stock to a news dependent ticker like other penny stocks. I think what we’re seeing now is the disparity between price and current fundamentals closing up. We’re just moving up towards fair value. RXMD—patience is of virtue.
Value investing at its finest :)
Agreed. Seasoned investors don’t look for back-to-back green days, but overall price trend. It’s hard to see the forest if you can’t see passed the trees. I think the churn we have here is healthy and also establishes a firm new base that we can move up from. Just looking at price action, we’ve had higher highs, and higher lows the last few weeks. If that’s not a blatant sign of where we’re headed, I don’t know what is. RXMD always had fundamentals but now it has the technicals, too.
As the saying goes, money can’t buy you class...no matter how much of it you have.
Agree with you when it comes to the other 99% of penny stocks, but RXMD is not like the 99%. Know what you hold.
2 more 65% days and we’ll be at .50 by the end of the week! Good to know that the market is starting to realize RXMD’s true value. Even at .50, with all the irons in the fire, RXMD is undervalued.
A range for split was proposed and confirmed but will only trigger if needed to uplist, as I understand it.
It takes years of work to become an overnight sensation. :) RXMD finally getting its day!
Just as confused. This reminds me of the saying, “beware those that knock on your door disguising themselves as friends.” Good to have you aboard the train, JQ. Let’s get RXMD to fair value!
The most important lesson RXMD has provided is that trading on technicals will allow you to scalp for beer money, and trading on fundamentals will buy you that chalet in the French Alps. RXMD has all the fundamentals you can ask for in an OTC (and soon to be Nasdaq) stock. Congrats to all the longs that saw through the day-to-day movements and realized the value that was worth the wait. Let’s keep climbing to fair value!
Hindsight is 20/20
$.30 is low even under current information that’s publicly available. Just on current fundamentals, this should be up between $.50 and a dollar, IMO. .$30 near-term, $.50 mid-term, and $1+ long-term, IMO.
Great DD. This post should be stickied! Looking forward to another great week ahead.
$.50 target is short-term and only with current fundamentals that accounts for $40.6M in revenue. If we get news of the NETE merger and become a $100M company, fair value is easily $1.25+, IMO. Add in all the other ovens in the fire (i.e. uplist to Nas) and the sky is the limit. Know what you hold folks! Going to get real interesting around these parts :)
Gotta love it when a plan comes together :)
Hold the proverbial RXMD line
This isn’t a P&D stock so don’t need news to move RXMD. RXMD is undervalued based on its own current merits and fundamentals. This is a rare value investment opportunity, IMO. Let’s not classify RXMD as a run of the mill penny stock by belittling it to a news reliant ticker. Let’s make sure folks know what they hold!
This might have been true before $40.6M in revenue and telehealth partnership announcement. Not to mention uplist and potential merger news that’s baking in the oven.
It’s key to know what you hold! 10 mins of due diligence, and it’s not hard to understand why RXMD is undervalued.
Price move up, and intermediate consolidation down is a good thing if you’re holding a stock with strong fundamentals, IMO. Anything that rises too quick, falls in the same manner. Slow and steady wins the race. The fundamentals haven’t gone away: $40M in revenue, uplist expected, merger prospect, growing physical and geographic footprint, etc. Fundamentals make and sustain stocks, not individual traders.
Those with a profit allergy...
This a value investors dream! Company with strong fundamentals that has a disparity between market cap and revenue/forward strategy. RXMD is only getting started. Buckle up folks!
IMO, RXMD is at least a $.50 stock on revenue alone. Add in uplist and merger prospect, and the sky is the limit.
This is easily $.50 based on revenue alone. Add in uplist and merger prospect, and it’s a clear path to dollar land. RXMD is headed towards true value in due time.
Stock split for uplist! RXMD leadership remaining loyal to shareholders as usual :)
Where can the S1 be found? Can someone share on the board? Thanks! Exciting times ahead! RXMD
Great summary article on what’s at play with RXMD. Our day is close...
https://oracledispatch.com/2020/08/20/progressive-care-inc-otcmktsrxmd-blows-out-q2-and-begins-exec-transition-to-ready-uplist/
RXMD being mentioned alongside Walgreens, CVS, and Allscripts! All behemoths in their own right. Know what you hold here...due diligence takes you a long way.
https://www.journaltranscript.com/2020/07/pharmacy-services-stocks-ready-to-rip-mdrx-rxmd-wba-cvs/
April news was fantastic imo, especially amid the Covid pandemic. This is another data point that shows RXMD is a solid business that’s laying down the foundations to weather all storms. You’d be hard pressed to find any other OTC company that’s building for the future. Nearly $3M revs and $2M cash position in the middle of a pandemic is proof of that.
Are you living in the same reality as everyone else on this board? Lol
It’s a cold day for shorts. Lol. RXMD